Is VRCA research on Rallies investment advice?

No. Rallies provides research, data, and educational context for VRCA. It does not provide personalized investment advice.

VRCA (Verrica Pharmaceuticals Inc. Common Stock) Stock Analysis - Financials

Verrica Pharmaceuticals Inc. Common Stock (VRCA) is a publicly traded Healthcare sector company. As of July 21, 2026, VRCA trades at $5.44 with a market cap of $94.31M and a P/E ratio of -4.97. VRCA moved -0.73% today. Year to date, VRCA is -34.54%; over the trailing twelve months it is -29.27%. Its 52-week range spans $3.28 to $13.20. Analyst consensus is buy with an average price target of $16.00. Rallies surfaces VRCA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are VRCA's key financials?

VRCA financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. VRCA recently traded at $5.44. Market cap is $94.31M. P/E ratio is -4.97. Revenue is $37.16M.

VRCA Key Metrics

Key financial metrics for VRCA
Metric	Value
Price	$5.44
Market Cap	$94.31M
P/E Ratio	-4.97
EPS	$-1.11
Dividend Yield	0.00%
52-Week High	$13.20
52-Week Low	$3.28
Volume	9.19K
Avg Volume	0
Revenue (TTM)	$37.16M
Net Income	$-17.83M
Gross Margin	0.00%

VRCA Analyst Consensus

3 analysts cover VRCA: 0 strong buy, 2 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $16.00.

Common questions about VRCA

What are VRCA's key financials?: VRCA financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. VRCA recently traded at $5.44. Market cap is $94.31M. P/E ratio is -4.97. Revenue is $37.16M.
Is VRCA research on Rallies investment advice?: No. Rallies provides research, data, and educational context for VRCA. It does not provide personalized investment advice.